Kisspeptin and Gynecological Cancer-Reference-Cited by-同舟云学术

Kisspeptin and Gynecological Cancer

Published:2020-07-03 Issue: Volume: Page:
ISSN:
Container-title:Proceedings of the Fourth International Conference on Biological Information and Biomedical Engineering
language:
Short-container-title:

Author:

Liu Bushangqing¹

Affiliation:

1. School of Medicine, Imperial College London, The UK

Publisher

ACM

Reference44 articles.

1. KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene

2. Lee JH Welch DR. (1997). Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene KiSS-1. Cancer Res; 57 2384--7. Lee JH Welch DR. (1997). Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene KiSS-1. Cancer Res; 57 2384--7.

3. Lee DK Nguyen T O'Neill GP Cheng R Liu Y Howard AD etal (1999). Discovery of a receptor related to the galanin receptors. FEBS Lett; 446 103--7. Lee DK Nguyen T O'Neill GP Cheng R Liu Y Howard AD et al. (1999). Discovery of a receptor related to the galanin receptors. FEBS Lett; 446 103--7.

4. Sun YB Xu S. (2013). Expression of KISS1 and KISS1R (GPR54) may be used as favorable prognostic markers for patients with non-small cell lung cancer. Int J Oncol; 43 521--30. Sun YB Xu S. (2013). Expression of KISS1 and KISS1R (GPR54) may be used as favorable prognostic markers for patients with non-small cell lung cancer. Int J Oncol; 43 521--30.

5. Zheng S Chang Y Hodges KB Sun Y Ma X Xue Y etal (2010). Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival. Anticancer Res; 30 713--8. Zheng S Chang Y Hodges KB Sun Y Ma X Xue Y et al. (2010). Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival. Anticancer Res; 30 713--8.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges;Cancers;2023-11-06